MADISON, Wis. , May 29, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2025. The management team is scheduled to participate in a fireside chat on Wednesday, June 4 th , 2025, at 5:30pm EDT / 2:30pm PDT . A live webcast of the call will also be available from the Investor Relations section of the company's website at... Read More

More than 40 Clinical Studies Using Accuray Technology Presented at ESTRO 2025; Company Highlights Innovation and Educational Symposia MADISON, Wis. , May 7, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the benefits of the company's CyberKnife ® System in the treatment of prostate cancer at... Read More

Medical Team's Use of Accuray CyberComm™ Reduced Commissioning Time by Approximately 50 Percent*, Enabling Them to Initiate Patient Treatments Sooner MADISON, Wis. , May 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the CyberKnife ® Center Salzburg is the first in Austria to treat patients with the CyberKnife ® System, expanding access to stereotactic radiosurgery (SRS) and... Read More

MADISON, Wis. , April 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2025 . Key Fiscal Third Quarter Highlights: Total net revenue was $113.2 million , an increase of 12 percent year-over-year Net loss was $1.3 million compared to a net loss of $6.3 million in the prior year period Adjusted EBITDA was $6.0 million compared to $1.1 million in... Read More

MADISON, Wis. , April 16, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2025, ended March 31, 2025 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on April 30, 2025 . The conference call dial-in numbers are 1-833-316-0563 ( USA ) or 1-412-317-5747 (international). In addition, a dial-up replay of the... Read More

Data Also Highlights Continued Clinical Advances Using the CyberKnife System That are Making High Quality Care an Option for People Who Previously Had Limited Choices MADISON, Wis. , April 3, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data on the clinical use of the CyberKnife ® System reinforce the device's broad-based radiation treatment capabilities for central nervous system (CNS)... Read More

MADISON, Wis. , March 12, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in the 37 th Annual Roth Conference taking place on March 16 -18, 2025 in Dana Point, California . Management will participate in a fireside chat on Tuesday, March 18, 2025 , at 9:30am PT / 12:30pm ET , and will be available for one-on-one meetings with investors. A live webcast of the fireside chat can be... Read More

MADISON, Wis. , Feb. 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2024 . Key Fiscal Q2 Highlights: Strong second quarter and first half results; raising fiscal year 2025 guidance Total net revenue was $116.2 million , an increase of 8 percent year-over-year Net income was $2.5 million compared to a net loss of $9.6 million in the prior... Read More

MADISON, Wis. , Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo ® C Radiation Treatment Delivery System, a product built in China through the CNNC-Accuray joint venture. Shandong Cancer Hospital and Institute was the first hospital in China to receive the new... Read More

MADISON, Wis. , Jan. 22, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2025, ended December 31, 2024 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on February 5, 2025 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747 (international). In addition, a dial-up replay of the... Read More

MADISON, Wis. , Jan. 21, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Leonel Peralta is joining the company as Senior Vice President, Chief Operations Officer, effective February 3, 2025 . Mr. Peralta will be responsible for leading worldwide manufacturing operations including driving alignment of operations with corporate business goals, maximizing supply chain profitability and efficiency,... Read More

MADISON, Wis. , Jan. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company's Radixact SynC™ System and CyberKnife ® S7™ System have been approved by the Chinese National Medical Products Administration (NMPA). With these approvals medical care teams can provide patients in China the most advanced Accuray radiation therapy solutions. The CyberKnife S7 System is the latest generation... Read More

Study Builds on Extensive Published Literature Highlighting the Benefits of the CyberKnife System in the Treatment of a Wide Range of Neurological Indications MADISON, Wis. , Dec. 18, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an international retrospective multicenter analysis found that radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT), delivered with the CyberKnife ® System... Read More

MADISON, Wis. , Nov. 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Mike Murphy , the company's new Vice President, Corporate Controller. As a material inducement to Mr. Murphy joining the company, and in accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation Committee approved granting Mr. Murphy an award of 150,000... Read More

Strong Start to Fiscal Year, Raises 2025 Guidance MADISON, Wis. , Nov. 6, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2024 "We continue to make solid progress in the execution of our strategic growth agenda and performed better than expected in the first quarter and are on track to deliver our fiscal 2025 plan. Our performance in the... Read More

MADISON, Wis. , Oct. 23, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, ended September 30, 2024 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on November 6, 2024 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747 (international). In addition, a dial-up replay of the... Read More

MADISON, Wis. , Oct. 21, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy , CPA has joined the company as Vice President, Corporate Controller. Mr. Murphy will be responsible for leading the global accounting function including corporate tax, regulatory reporting, accounting policies, and risk management, along with associated budgetary and administrative operations. He will report... Read More

The Precision of Stereotactic Body Radiation Therapy (SBRT), an Advanced Treatment Technique, Enables Treatment in Five Days, Significantly Reducing the Time Men Must Spend Undergoing Care MADISON, Wis. , Oct. 17, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that results of the PACE-B – Prostate Advances in Comparative Evidence – trial were published in the New England Journal of Medicine (NEJM).... Read More

MADISON, Wis. , Oct. 15, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, effective as of today, Suzanne Winter has returned from her temporary medical leave and assumed her full duties as President and Chief Executive Officer. Sandeep Chalke , who has served as interim CEO during Ms. Winter's absence, will continue in his position as Senior Vice President and Chief Commercial Officer. "On behalf of... Read More

Accuray is the first industry partner to open a facility at the Genolier Innovation Hub, created to provide opportunities for clinician-industry collaborations that can help accelerate improvements in patient care New Accuray CyberComm™ tool was used to significantly reduce the CyberKnife ® S7™ System's commissioning time and enable product training in Genolier to begin more quickly MADISON, Wis. , Sept. 30, 2024... Read More

The Technology Will Play an Important Role in the Hospital's Plan to Expand Patient Access to High Precision Radiation Therapy Treatments MADISON, Wis. , Sept. 10, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Gifu Prefectural General Medical Center is setting a new standard in cancer care in Japan as the first hospital in the country to treat patients with surface-guided radiation therapy... Read More

MADISON, Wis. , Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately. Accuray Senior Vice President and Chief Commercial Officer Sandeep Chalke will serve as the interim CEO during Ms. Winter's absence. To ensure that... Read More

Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority Drives the next phase of company's strategic plan to expand its portfolio of helical radiation therapy delivery systems MADISON, Wis. , Aug. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark for Accuray... Read More

14% Revenue and 8% Orders Growth in Q4; Company issues FY25 Guidance MADISON, Wis. , Aug. 14, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2024, ended June 30, 2024 . Fourth Quarter Fiscal 2024 Summary Net revenue of $134.3 million , an increase of 13.5 percent from the same period in the prior fiscal year. Net revenue on a constant currency basis... Read More

New Technology Provides Advanced Patient Positioning Capabilities With the Radixact System, Making it Easier to Deliver Fast and Effective Radiotherapy Treatments MADISON, Wis. and DAYTONA BEACH, Fla. , Aug. 13, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and Halifax Health, in Volusia County, Florida , announced... Read More

MADISON, Wis. , July 31, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2024, ended June 30, 2024 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on August 14, 2024 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747 (international). In addition, a dial-up replay of the... Read More

The Radixact System will be supplied with ClearRT ® , Synchrony ® , and the VOLO™ Ultra Optimizer to enhance radiation treatment delivery precision and speed Heidelberg University Hospital is recognized worldwide for excellence in patient care and practice changing research MADISON, Wis. , June 27, 2024 /PRNewswire/ -- Accuray... Read More

MADISON, Wis. , June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-party support designed to enhance their department's capabilities. Under the terms of the agreement, TrueNorth Medical Physics will offer services that are complementary and supplementary to those supplied by Accuray, acting as... Read More

MADISON, Wis. , June 12, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray Precision ® Treatment Planning System (TPS) has been approved by the Chinese National Medical Products Administration (NMPA). The Accuray Precision TPS is now available for use with the CNNC-Accuray joint venture Tomo ® C radiation therapy system and in combination, will provide... Read More

MADISON, Wis. , May 22, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024. The management team is scheduled to participate in a fireside chat on Wednesday, June 5, 2024 at 7:30am EDT / 4:30am PDT A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com . A... Read More

MADISON, Wis. , May 1, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter and nine-months ended March 31, 2024 . Third Quarter Fiscal 2024 Summary Net revenue of $101.1 million decreased 14 percent from the same period in the prior fiscal year. Net revenue on a constant currency basis was $102.4 million , which represented a 13 percent decrease from the same period... Read More

Celebrates 30 Years of Innovation Through Collaboration and the Development of Technologies That Have Helped Set the Standard of Care for the Industry MADISON, Wis. , April 25, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife ® and... Read More

The new center is the most recent addition to the company's existing training hubs in Madison, Wisconsin (U.S.), Tokyo, Japan and Tianjin, China Each facility offers a range of educational opportunities designed to advance patient care using the Accuray CyberKnife ® and Radixact ® Systems MADISON, Wis. , April 18, 2024... Read More

MADISON, Wis. , April 17, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2024, ended March 31, 2024 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on May 1, 2024 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747 (international). In addition, a dial-up replay of the conference... Read More

Data Also Underscores Potential Benefits of CyberKnife System Sub-millimeter Accuracy in Preserving Quality of Life after Treatment for Prostate Cancer MADISON, Wis. , March 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the 2024 Radiosurgery Society Meeting in Chicago,... Read More

Company to Take Part in Fireside Chat Monday, March 18, 2024 at 12:30pm PST / 3:30pm EST MADISON, Wis. , March 4, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 36 th Annual Roth Conference. The management team is scheduled to take part in a fireside chat on Monday, March 18, 2024 at 12:30pm PST / 3:30pm EST . A live webcast of the fireside chat can be accessed on the... Read More

Company to Take Part in Fireside Chat Tuesday, March 12, 2024 at 7:00am PST / 10:00am EST MADISON, Wis. , Feb. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference taking place March 12-13, 2024 . The management team is scheduled to participate in a fireside chat on Tuesday, March 12, 2024 at 7:00am PST / 10:00am... Read More

Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital, is a center of excellence and recognized leader in the treatment of cancer in the province of Quebec The Radixact System is equipped with ClearRT™ and Synchrony ® , advanced technologies designed to improve treatment outcomes for more patients each day MADISON, Wis. , Feb. 13, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that... Read More

MADISON, Wis. , Feb. 5, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place on February 13, 2024 . BTIG-hosted events are intended for prospective and existing BTIG clients only. To request a one-on-one meeting with management, please contact your BTIG representative with interest. About... Read More

19% Order Growth YOY; 8% Service Revenue Expansion; Confirms FY24 Guidance MADISON, Wis. , Jan. 31, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter and six-months ended December 31, 2023 . Second Quarter Fiscal 2024 Summary Net revenue of $107.2 million increased 3 percent sequentially and decreased 7 percent from the same period in the prior fiscal year. Net... Read More

New System Will Play a Key Role in Delivering Radiation Treatments in One of the Largest Cancer Facilities in Washington State MADISON, Wis. , Jan. 25, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Providence Swedish Radiosurgery Center in Seattle, Washington is enhancing its cancer... Read More

MADISON, Wis. , Jan. 16, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2024, ended December 31, 2023 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on January 31, 2024 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747 (international). In addition, a dial-up replay of the... Read More

MADISON, Wis. , Dec. 5, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has initiated sales of the VitalHold™* package supporting surface-guided radiation therapy (SGRT) on the Radixact ® System in Japan beginning November 30, 2023 . The VitalHold feature incorporates SGRT capability on the Radixact System using the Catalyst+ HD system manufactured by C-RAD, making it possible to... Read More

Company Achieves 8% Revenue Growth, Reiterates FY 2024 Guidance MADISON, Wis. , Nov. 7, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2024 ended September 30, 2023 . First Quarter Fiscal 2024 Summary Net revenue of $103.9 million increased 7.7 percent from the same period in the prior fiscal year. Net revenue on a constant currency basis was $102.7... Read More

MADISON, Wis. , Oct. 31, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 14 th Annual Jefferies London Healthcare Conference. The management team is scheduled to participate in a presentation with moderated Q&A on Wednesday, November 15 th , 2023 at 9:00am GMT / 4:00am EST . A live webcast of the presentation can be accessed on the Investor Relations section of the company's... Read More

MADISON, Wis. , Oct. 26, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2024, ended September 30, 2023 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on November 7, 2023 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747 (international). In addition, a dial-up replay of the... Read More

MADISON, Wis. , Oct. 3, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo ® C radiation therapy system for the Type B market has been approved by the Chinese National Medical Products Administration (NMPA). The new, made in China system, is the first joint venture product and represents an important achievement on behalf of cancer... Read More

MADISON, Wis. , Oct. 2, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has a 510(k) pending for an online adaptive therapy option*, Cenos™, for its Radixact ® System. The solution was unveiled, in partnership with Limbus AI, at the 2023 ASTRO (American Society for Radiation Oncology) Annual Meeting in San Diego, California , October 1-4, 2023 . Cenos is designed to enable medical... Read More

Large classrooms and a hybrid, in-person/remote connection option will make it easier for more care providers to remain current on best practices and innovations in radiation therapy New center is part of the company's comprehensive education program which also includes on-site training, online microlearning and cloud-hosted courses, as well as Accuray Exchange, a platform for peer-to-peer exchange MADISON, Wis. , Sept. 18,... Read More

MADISON, Wis. , Sept. 14, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Tuesday, October 3, 2023 , in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting. The event will take place in person at the ASTRO meeting and on a virtual platform, with presentations beginning at 1:30 pm PT ( 4:30 pm ET ).... Read More

The Radixact System, with the addition of the VitalHold functionality, provides clinicians with unmatched choice of radiation treatment delivery options in one device Treatment delivery versatility offers opportunities for personalization and makes exceptional quality care possible for more breast cancer patients MADISON, Wis.... Read More

8% Q4 revenue growth; Record shipments for FY23; Company issues guidance for FY24 MADISON, Wis. , Aug. 9, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2023, ended June 30 , 2023. Fourth Quarter Fiscal 2023 Summary Net revenue of $118.3 million , an increase of 7.5 percent from the same period in the prior fiscal year. Net revenue on a constant... Read More

SUNNYVALE, Calif. , July 26, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2023, ended June 30, 2023 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on August 9, 2023 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747 (international). In addition, a dial-up replay of the... Read More

SUNNYVALE, Calif. , June 26, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that as part of the annual reconstitution of the Russell stock indexes, the Company will be included in the Russell 2000 ® Index and the broad-market Russell 3000 ® Index, which will be effective today. "We are pleased to have earned inclusion in the Russell 2000 ® Index, one of the most widely used benchmarks for small-cap... Read More

Partnership Will Support Accuray with SAP S/4HANA Implementation TEANECK, N.J. , June 21, 2023 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it is partnering with Accuray Incorporated (NASDAQ: ARAY) to support the company's deployment of SAP S/4HANA to obtain better data and analytics, and achieve greater business efficiencies. Accuray develops, manufactures, and sells radiotherapy systems for the precise,... Read More

SUNNYVALE, Calif. , June 15, 2023 /PRNewswire/ -- The global Accuray Incorporated (NASDAQ: ARAY) team is proud to announce that president and CEO Suzanne Winter has been recognized by The Healthcare Technology Report as one of the Top 50 Healthcare Technology CEOs of 2023. This year's awardees, some of the most accomplished executives in the industry, represent a wide range of healthcare technology organizations. Their... Read More

Data Highlight Expanding Use of (Ultra) Hypofractionated Treatments, Benefits in Patient Care Made Possible by the Precision and Accuracy of Accuray Technologies SUNNYVALE, Calif. , May 17, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the benefits of the company's CyberKnife ® and TomoTherapy ®... Read More

Company delivers record quarterly revenue and unit volume in Q3; Reiterates fiscal year guidance SUNNYVALE, Calif. , April 26, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter of fiscal 2023 ended March 31, 2023 . Third Quarter Fiscal 2023 Summary Net revenue of $118.1 million increased 22.8 percent from the same period in the prior fiscal year. Net revenue on a... Read More

SUNNYVALE, Calif. , April 13, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2023, ended March 31, 2023 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on April 26, 2023 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747 (international). In addition, a dial-up replay of the... Read More

Company to Take Part in Fireside Chat Tuesday, March 14, 2023 at 1:00pm PST / 4:00pm EST SUNNYVALE, Calif. , March 8, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 33 rd Annual Oppenheimer Healthcare Conference taking place March 13-15, 2023. The management team is scheduled to participate in a fireside chat on Tuesday, March 14, 2023 at 1:00pm PST / 4:00pm EST. A live... Read More

Company to Take Part in Fireside Chat Monday, March 6, 2023 at 10:30am PST / 1:30pm EST SUNNYVALE, Calif. , Feb. 21, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Cowen 43 rd Annual Health Care Conference taking place March 6-8, 2022 . The management team is scheduled to participate in a Fireside Chat on Monday, March 6, 2023 at 10:30am PST / 1:30pm EST . A live webcast of... Read More

SUNNYVALE, Calif. , Feb. 16, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from the randomized, multicenter trial PACE-A (PACE - Prostate Advances in Comparative Evidence) indicates that stereotactic body radiation therapy (SBRT), in comparison to surgery, better preserves urinary continence and sexual function in men with localized prostate cancer. The study, which was led by The Royal... Read More

SUNNYVALE, Calif. , Feb. 7, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 14-16, 2023 . BTIG-hosted events are intended for prospective and existing BTIG clients only. To request a one-on-one meeting with management or to listen to the live event, please contact your... Read More

SUNNYVALE, Calif. , Feb. 1, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Robert C. Kill to the company's Board of Directors, effective as of January 30, 2023 . Mr. Kill is a skilled healthcare executive with more than 30 years' experience transforming various healthcare-related companies. In his most recent executive position as CEO of Parata Systems, Mr. Kill grew company... Read More

Delivered strong Q2 performance amidst challenging macroenvironment; Reiterate fiscal year guidance SUNNYVALE, Calif. , Feb. 1, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter of fiscal 2023 ended December 31, 2022 . Second Quarter Fiscal 2023 Summary Gross orders of $79.0 million decreased 7.4 percent from the same period in the prior fiscal year and increased... Read More

Center believes the CyberKnife System is the #1 tool for delivery of advanced radiosurgery treatments Selected the latest generation CyberKnife S7™ System to increase the number of indications they can treat throughout the body, and the patients they can help SUNNYVALE, Calif. , Jan. 26, 2023 /PRNewswire/ -- Accuray... Read More

SUNNYVALE, Calif. , Jan. 18, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2023, ended December 31, 2022, after the market close on February 1, 2023. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m. ET on the same day. The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747... Read More

Auckland Radiation Oncology Selected the Latest-Generation CyberKnife S7™ System to Deliver Precise Treatments More Quickly, so Patients Can Rapidly Return to the Activities They Enjoy SUNNYVALE, Calif. , Jan. 17, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Auckland Radiation Oncology (ARO) is the first center in New Zealand to treat patients with the CyberKnife ® System, a robotic radiation... Read More

Company to Take Part in Fireside Chat Wednesday, January 18, 2023 at 7:00am PST / 10:00am EST SUNNYVALE, Calif. , Jan. 10, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the B. Riley Securities' 3rd Annual Oncology Conference taking place January 18-19, 2023 . The management team is scheduled to participate in a virtual Fireside Chat on Wednesday, January 18, 2023 at 7:00am PST... Read More